yttrium radioisotopes has been researched along with Cancer of ILEUM in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bencze, A; Igaz, P; Leiszter, K; Nagy, Z; Patócs, A; Rácz, K; Szücs, N | 1 |
August, C; Maker, AV; Maker, VK; Weisenberg, E | 1 |
Campana, D; Capurso, G; Delle Fave, G; Merola, E; Monarca, B; Panzuto, F; Tomassetti, P | 1 |
Agazzi, A; Aricò, D; Bodei, L; De Cicco, C; De Simone, M; Pacifici, M; Paganelli, G; Quarna, J; Sansovini, M; Sierra, ML | 1 |
4 other study(ies) available for yttrium radioisotopes and Cancer of ILEUM
Article | Year |
---|---|
[Carcinoid heart disease].
Topics: Carcinoid Heart Disease; Diagnosis, Differential; Echocardiography, Doppler, Color; Flushing; Humans; Ileal Neoplasms; Lymphatic Metastasis; Male; Malignant Carcinoid Syndrome; Middle Aged; Octreotide; Prognosis; Radiotherapy, Adjuvant; Severity of Illness Index; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis.
Topics: Carcinoid Tumor; Embolization, Therapeutic; Female; Hepatectomy; Hepatic Artery; Humans; Ileal Neoplasms; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Yttrium Radioisotopes | 2016 |
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid.
Topics: Aged; Carcinoid Tumor; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Ileal Neoplasms; Male; Octreotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Peptide; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2010 |
Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC.
Topics: Adult; Aged; B-Lymphocytes; Colonic Neoplasms; Duodenal Neoplasms; Female; Humans; Ileal Neoplasms; Lung Neoplasms; Lutetium; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Yttrium Radioisotopes | 2009 |